From platelet-rich plasma to the reverse prosthesis: controversies in treating rotator cuff pathology.
Rotator cuff pathology and tearing remains a common cause of shoulder pain and disability. Although little controversy and disagreement exists regarding the treatment of small to moderate size tears in good quality tissue without retraction, there is difficulty in agreeing on the ideal treatment of the largest tears, particularly because those tears may be accompanied by widely variable levels of pain and function. Clinical decision making is made more difficult because of the variable presentations observed in patients with a documented full-thickness rotator cuff tear: some have good function and no pain, some have good function and pain, some have poor function and no pain, and some have both poor function and pain. The role of biologics as an adjunct in treating most rotator cuff tears remains unclear, with ongoing exploration of the roles of stem cells, growth factors, and platelet-rich plasma. In patients with unreconstructable tears with marked weakness in external rotation but good elevation, a latissimus transfer may restore rotation. Patches may play a role in partial repairs while serving as both a lattice for healing and a biomechanical anchoring point for sutures. In patients with massive tears and arthritis and in many who have rotator cuff insufficiency, pseudoparalysis, or anterosuperior escape without arthritis, reverse shoulder arthroplasty has led to improvements in pain and strength and revolutionized the treatment of rotator cuff tears.
Attending Surgeon, Department of Orthopedics, Hospital for Special Surgery, New York, New York.
Edward V
EV
Craig
Leesa M
LM
Galatz
John W
JW
Sperling
D001178:Arthroplasty; D006801:Humans; D007595:Joint Prosthesis; D053657:Platelet-Rich Plasma; D016059:Range of Motion, Articular; D000070636:Rotator Cuff Injuries; D000070599:Shoulder Injuries; D020069:Shoulder Pain / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome